Anatara Lifesciences Ltd - Asset Resilience Ratio

Latest as of December 2024: 2.84%

Anatara Lifesciences Ltd (ANR) has an Asset Resilience Ratio of 2.84% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Anatara Lifesciences Ltd carry for a breakdown of total debt and financial obligations.

Liquid Assets

AU$50.00K

≈ $35.38K USD Cash + Short-term Investments

Total Assets

AU$1.76 Million

≈ $1.25 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2024)

This chart shows how Anatara Lifesciences Ltd's Asset Resilience Ratio has changed over time. See ANR net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Anatara Lifesciences Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Anatara Lifesciences Ltd worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$0.00	0%
Short-term Investments	AU$50.00K	2.84%
Total Liquid Assets	AU$50.00K	2.84%

Asset Resilience Insights

Limited Liquidity: Anatara Lifesciences Ltd maintains only 2.84% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Anatara Lifesciences Ltd Industry Peers by Asset Resilience Ratio

Compare Anatara Lifesciences Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	3.28%
Ascendis Pharma AS F:A71	Biotechnology	0.00%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	0.00%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Sinopep-Allsino Biopharmaceutical Co. Ltd. A SHG:688076	Biotechnology	1.39%
Wuhan Keqian Biology Co Ltd SHG:688526	Biotechnology	19.42%
R&G PharmaStudies Co. Ltd. A SHE:301333	Biotechnology	35.96%
Shanghai Shen Lian Biomedical Corp SHG:688098	Biotechnology	3.87%

Annual Asset Resilience Ratio for Anatara Lifesciences Ltd (2015–2024)

The table below shows the annual Asset Resilience Ratio data for Anatara Lifesciences Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-06-30	3.00%	AU$50.09K ≈ $35.44K	AU$1.67 Million ≈ $1.18 Million	-0.53pp
2023-06-30	3.52%	AU$50.00K ≈ $35.38K	AU$1.42 Million ≈ $1.00 Million	+0.69pp
2022-06-30	2.83%	AU$50.00K ≈ $35.38K	AU$1.77 Million ≈ $1.25 Million	+1.67pp
2021-06-30	1.16%	AU$50.00K ≈ $35.38K	AU$4.33 Million ≈ $3.06 Million	--
2020-06-30	0.00%	AU$0.00 ≈ $0.00	AU$3.34 Million ≈ $2.37 Million	--
2019-06-30	63.46%	AU$4.05 Million ≈ $2.87 Million	AU$6.38 Million ≈ $4.52 Million	+0.27pp
2018-06-30	63.19%	AU$6.20 Million ≈ $4.39 Million	AU$9.81 Million ≈ $6.94 Million	-24.99pp
2017-06-30	88.17%	AU$10.86 Million ≈ $7.68 Million	AU$12.32 Million ≈ $8.71 Million	+34.74pp
2016-06-30	53.43%	AU$7.44 Million ≈ $5.26 Million	AU$13.92 Million ≈ $9.85 Million	-18.59pp
2015-06-30	72.03%	AU$4.05 Million ≈ $2.87 Million	AU$5.63 Million ≈ $3.98 Million	--

pp = percentage points

About Anatara Lifesciences Ltd

AU:ANR Australia Biotechnology

Market Cap

$1.57 Million

AU$2.23 Million AUD

Market Cap Rank

#29892 Global

#1773 in Australia

Share Price

AU$0.01

Change (1 day)

+0.00%

52-Week Range

AU$0.01 - AU$0.02

All Time High

AU$1.64